drugset / Trial / NCT00171379

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant

NCT00171379

Phase 3 Completed 162 enrolled Novartis
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The aim of the study is to evaluate the safety and efficacy of equimolar conversion from MMF to enteric-coated mycophenolate sodium, in renal transplant patients receiving cyclosporine.

Timeline

Start
2004-03
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Sodium Unknown